v3.25.1
Share-based Compensation (Tables)
3 Months Ended
Mar. 31, 2025
Share-based Compensation  
Schedule of share-based compensation expense

Three months ended March 31,

    

2025

    

2024

    

(in thousands)

Cost of sales

 

$

1,343

 

$

1,730

 

Research and development

3,048

2,318

Selling, general, and administrative

4,817

4,034

Total

$

9,208

$

8,082

Summary of non-vested restricted and performance shares activity

    

    

Weighted

Average

Number of

Grant Date

Shares

Fair Value

(in thousands)

Balance - December 31, 2024

2,604

$

32.53

Granted

1,061

23.23

Performance award adjustments

(21)

45.28

Vested

(843)

31.64

Forfeited

(20)

29.83

Balance - March 31, 2025

2,781

$

29.17